Results 211 to 220 of about 3,799,411 (412)

A Phase 3 Multicenter, Double‐Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal Osteoporosis

open access: yesAGING MEDICINE, Volume 8, Issue 3, Page 267-274, June 2025.
This phase III study demonstrated that Alkem's biosimilar teriparatide is noninferior to reference teriparatide in improving bone mineral density at the lumbar spine and femoral neck in postmenopausal osteoporosis patients, with comparable safety, pharmacodynamics, and immunogenicity profiles over 48 weeks of treatment.
Nitin Kapoor   +18 more
wiley   +1 more source

Whole-body metabolism during and after abdominal surgery [PDF]

open access: bronze, 1969
Otto H. Horrelt   +2 more
openalex   +1 more source

A multicenter randomized controlled trial evaluating the effect of the use of an anti‐adhesion barrier for diverting ileostomy on the multidimensional workload in minimally invasive surgery for rectal cancer (YCOG 2005: The ADOBARRIER study)

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This multicenter, single‐blind, randomized, controlled trial was conducted to evaluate the multidimensional workload of the first operator during ileostomy closure using the SURG‐TLX between groups with and without the use of the spray‐type anti‐adhesion material during diverting ileostomy construction.
Emi Ota   +8 more
wiley   +1 more source

Multimodal Prehabilitation in Major Abdominal Surgery-Rationale, Modalities, Results and Limitations. [PDF]

open access: yesMedicina (Kaunas)
Popescu GA   +6 more
europepmc   +1 more source

Intercostal Nerve Block in Upper Abdominal and Chest Surgery.

open access: bronze, 1956
Howard A. Bennett   +2 more
openalex   +1 more source

FIB‐3 index as a novel age‐independent predictor of liver fibrosis and prognosis in hepatocellular carcinoma patients undergoing hepatectomy

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Fibrosis‐3 index (FIB‐3) can stratify the risk of the survival and the recurrence‐free survival. The FIB‐3 index is a reliable, age‐independent tool for assessing liver fibrosis and prognosis in HCC patients post‐hepatectomy. Its use may improve clinical outcomes and support personalized treatment strategies. Abstract Background Liver fibrosis is a key
Yuki Imaoka   +13 more
wiley   +1 more source

Graft Loss Due to Thrombosis of an Aortic Conduit in a Pediatric Multivisceral Transplant Recipient

open access: yesTransplantation Direct, 2018
Mariya L. Samoylova, MD   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy